Our | Products


CABAZIL





THERAPEUTIC AREA: Oncology
ACTIVE PRINCIPLE: Cabazitaxel
PRESENTATION: 0,50 mg x 28 hard capsules
INDICATION:

  • Prostate Cancer

COUNTRIES WHERE IT IS MARKETED:
Argentina